{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:09:16Z","timestamp":1791036556507,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Artemisinin-based combination therapy (ACT) has been recommended for the treatment of <jats:italic>falciparum<\/jats:italic> malaria by the World Health Organization. Though India has already switched to ACT for treating <jats:italic>falciparum<\/jats:italic> malaria, there is need to have multiple options of alternative forms of ACT. A randomized trial was conducted to assess the safety and efficacy of the fixed dose combination of artesunate-amodiaquine (ASAQ) and amodiaquine (AQ) for the treatment of uncomplicated <jats:italic>falciparum<\/jats:italic> malaria for the first time in India. The study sites are located in malaria-endemic, chloroquine-resistant areas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This was an open label, randomized trial conducted at two sites in India from January 2007 to January 2008. Patients between six months and 60 years of age having <jats:italic>Plasmodium falciparum<\/jats:italic> mono-infection were randomly allocated to ASAQ and AQ arms. The primary endpoint was 28-day PCR-corrected parasitological cure rate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Three hundred patients were enrolled at two participating centres, Ranchi, Jharkhand and Rourkela, Odisha. Two patients in AQ arm had early treatment failure while there was no early treatment failure in ASAQ arm. Late treatment failures were seen in 13 and 12 patients in ASAQ and AQ arms, respectively. The PCR-corrected cure rates in intent-to-treat population were 97.51% (94.6-99.1%) in ASAQ and 88.65% (81.3-93.9%) in AQ arms. In per-protocol population, they were 97.47% (94.2-99.2%) and 88.30% (80-94%) in ASAQ and AQ arms respectively. Seven serious adverse events (SAEs) were reported in five patients, of which two were reported as related to the treatment. All SAEs resolved without sequel.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The fixed dose combination of ASAQ was found to be efficacious and safe treatment for <jats:italic>P. falciparum<\/jats:italic> malaria. Amodiaquine also showed acceptable efficacy, making it a suitable partner of artesunate. The combination could prove to be a viable option in case India opts for fixed dose combination ACT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical trial registry<\/jats:title>\n            <jats:p>\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.controlled-trials.com\/ISRCTN84408319\" ext-link-type=\"uri\">ISRCTN84408319<\/jats:ext-link>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1475-2875-11-97","type":"journal-article","created":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T06:16:19Z","timestamp":1333088179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in India"],"prefix":"10.1186","volume":"11","author":[{"given":"Anupkumar R","family":"Anvikar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhawna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhartendu H","family":"Shahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajesh K","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarit K","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya K","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakriti","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bina","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean R","family":"Kiechel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya P","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Valecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,30]]},"reference":[{"key":"2070_CR1","volume-title":"Guidelines for the treatment of malaria. Second Edition","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: Guidelines for the treatment of malaria. Second Edition. 2010, WHO, Geneva, Switzerland, [http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241547925\/en\/index.html]"},{"key":"2070_CR2","volume-title":"National drug policy on malaria","author":"National Vector Borne Disease Control Programme","year":"2010","unstructured":"National Vector Borne Disease Control Programme: National drug policy on malaria. 2010, Directorate of Health Services, Government of India, [http:\/\/nvbdcp.gov.in\/Doc\/drug-policy-2010.pdf]"},{"key":"2070_CR3","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1128\/AAC.48.3.879-889.2004","volume":"48","author":"A Ahmed","year":"2004","unstructured":"Ahmed A, Bararia D, Vinayak S, Yameen M, Biswas S, Dev V, Kumar A, Ansari AM, Sharma YD: Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance. Antimicrob Agents Chemother. 2004, 48: 879-889. 10.1128\/AAC.48.3.879-889.2004.","journal-title":"Antimicrob Agents Chemother"},{"key":"2070_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1473-3099(10)70214-0","volume":"11","author":"NK Shah","year":"2011","unstructured":"Shah NK, Dhillon GP, Dash AP, Arora U, Meshnick SR, Valecha N: Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space. Lancet Infect Dis. 2011, 11: 57-64. 10.1016\/S1473-3099(10)70214-0.","journal-title":"Lancet Infect Dis"},{"key":"2070_CR5","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(02)08348-4","volume":"359","author":"M Adjuik","year":"2002","unstructured":"Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, Cobelens F, Diallo S, Faucher JF, Garner P, Gikunda S, Kremsner PG, Krishna S, Lell B, Loolpapit M, Matsiegui PB, Missinou MA, Mwanza J, Ntoumi F, Olliaro P, Osimbo P, Rezbach P, Some E, Taylor WR: Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised multicentre trial. Lancet. 2002, 359: 1365-1372. 10.1016\/S0140-6736(02)08348-4.","journal-title":"Lancet"},{"key":"2070_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.actatropica.2005.06.018","volume":"95","author":"KA Koram","year":"2005","unstructured":"Koram KA, Abuaku B, Duah N, Quashie N: Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. Acta Trop. 2005, 95: 194-203. 10.1016\/j.actatropica.2005.06.018.","journal-title":"Acta Trop"},{"key":"2070_CR7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.trstmh.2004.10.003","volume":"99","author":"S Hamour","year":"2005","unstructured":"Hamour S, Melaku Y, Keus K, Wambugu J, Atkin S, Montgomery J, Ford N, Hook C, Checchi F: Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations. Trans R Soc Trop Med Hyg. 2005, 99: 548-554. 10.1016\/j.trstmh.2004.10.003.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2070_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1365-3156.2004.01224.x","volume":"9","author":"H Barennes","year":"2004","unstructured":"Barennes H, Nagot N, Valea I, Koussoub\u00e9-Balima T, Ouedraogo A, Sanou T, Y\u00e9 S: A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso. Trop Med Int Health. 2004, 9: 438-444. 10.1111\/j.1365-3156.2004.01224.x.","journal-title":"Trop Med Int Health"},{"key":"2070_CR9","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/S0140-6736(96)06217-4","volume":"2","author":"P Olliaro","year":"1996","unstructured":"Olliaro P, Nevill C, LeBras J, Ringwald P, Mussano P, Garner P, Brasseur P: Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet. 1996, 2: 1196-1201.","journal-title":"Lancet"},{"key":"2070_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.actatropica.2009.01.013","volume":"111","author":"N Valecha","year":"2009","unstructured":"Valecha N, Joshi H, Mallick PK, Sharma SK, Kumar A, Tyagi PK, Shahi B, Das MK, Nagpal BN, Dash AP: Low efficacy of chloroquine: time to switchover to artemisinin-based combination therapy for falciparum malaria in India. Acta Trop. 2009, 111: 21-28. 10.1016\/j.actatropica.2009.01.013.","journal-title":"Acta Trop"},{"key":"2070_CR11","volume-title":"Assessment and monitoring of anti-malarial drug efficacy for the treatment of uncomplicated falciparum malaria Geneva","author":"World Health Organization","year":"2003","unstructured":"World Health Organization: Assessment and monitoring of anti-malarial drug efficacy for the treatment of uncomplicated falciparum malaria Geneva. 2003, [http:\/\/www.emro.who.int\/rbm\/publications\/protocolwho.pdf]"},{"key":"2070_CR12","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0035-9203(99)90120-7","volume":"93","author":"G Snounou","year":"1999","unstructured":"Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S: Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans R Soc Trop Med Hyg. 1999, 93: 369-374. 10.1016\/S0035-9203(99)90120-7.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2070_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1475-2875-8-125","volume":"8","author":"JL Ndiaye","year":"2009","unstructured":"Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore M, Dicko Y, Dara N, Lameyre V, Diallo M, Djimde A, Ekobo AS, Gaye O: Randomized, multicentre assessment of the efficacy and safety of ASAQ - a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Malar J. 2009, 8: 125-10.1186\/1475-2875-8-125.","journal-title":"Malar J"},{"key":"2070_CR14","first-page":"608","volume":"15","author":"B Faye","year":"2010","unstructured":"Faye B, Offianan AT, Ndiaye JL, Tine RC, Tour\u00e9 W, Djoman K, Sylla K, Ndiaye PS, Penali L, Gaye O: Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast. Trop Med Int Health. 2010, 15: 608-613.","journal-title":"Trop Med Int Health"},{"key":"2070_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1473-3099(10)70187-0","volume":"10","author":"F Smithuis","year":"2010","unstructured":"Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo AP, Naing AL, Nyo MY, Myint NZ, Imwong M, Ashley E, Lee SJ, White NJ: Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis. 2010, 10: 673-681. 10.1016\/S1473-3099(10)70187-0.","journal-title":"Lancet Infect Dis"},{"key":"2070_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/1475-2875-10-237","volume":"10","author":"JL Ndiaye","year":"2011","unstructured":"Ndiaye JL, Faye B, Gueye A, Tine R, Ndiaye D, Tchania C, Ndiaye I, Barry A, Ciss\u00e9 B, Lameyre V, Gaye O: Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Malar J. 2011, 10: 237-10.1186\/1475-2875-10-237.","journal-title":"Malar J"},{"key":"2070_CR17","unstructured":"National Institute of Malaria Research: Annual Report 2010-11. NIMR, Delhi, [http:\/\/www.mrcindia.org\/annual-rep\/2010-11.pdf]"},{"key":"2070_CR18","first-page":"65","volume":"40","author":"WR Taylor","year":"2003","unstructured":"Taylor WR, Rigal J, Olliaro PL: Drug resistant falciparum malaria and the use of artesunate-based combinations: focus on clinical trials sponsored by TDR. J Vector Borne Dis. 2003, 40: 65-72.","journal-title":"J Vector Borne Dis"},{"key":"2070_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4269\/ajtmh.2012.11-0047","volume":"86","author":"A Ratsimbasoa","year":"2012","unstructured":"Ratsimbasoa A, Ravony H, Vonimpaisomihanta JA, Raherinjafy R, Jahevitra M, Rapelanoro R, Rakotomanga Jde D, Malvy D, Millet P, M\u00e9nard D: Compliance, safety, and effectiveness of fixed-dose artesunate-amodiaquine for presumptive treatment of non-severe malaria in the context of home management of malaria in Madagascar. Am J Trop Med Hyg. 2012, 86: 203-210. 10.4269\/ajtmh.2012.11-0047.","journal-title":"Am J Trop Med Hyg"},{"key":"2070_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1475-2875-10-127","volume":"10","author":"CK Ahorlu","year":"2011","unstructured":"Ahorlu CK, Koram KA, Seake-Kwawu A, Weiss MG: Two-year evaluation of Intermittent Preventive Treatment for Children (IPTc) combined with timely home treatment for malaria control in Ghana. Malar J. 2011, 10: 127-10.1186\/1475-2875-10-127.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-11-97.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:59:56Z","timestamp":1630522796000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-11-97"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,30]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2070"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-11-97","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,30]]},"assertion":[{"value":"11 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"97"}}